
IHC-P analysis of human liver tissue using GTX85281 MACC1 antibody. Working concentration : 2.5 microg/ml
MACC1 antibody
GTX85281
Overview
- SupplierGeneTex
- Product NameMACC1 antibody
- Delivery Days Customer9
- Application Supplier NoteWB: 1 - 2 microg/mL. IHC-P: 2.5 microg/mL. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- Concentration1 mg/ml
- FormulationLiquid
- Gene ID346389
- Target nameMACC1
- Target descriptionMET transcriptional regulator MACC1
- Target synonyms7A5; MACC1, MET transcriptional regulator; metastasis associated in colon cancer 1; metastasis-associated in colon cancer protein 1; putative binding protein 7a5; SH3 domain-containing protein 7a5; SH3BP4L
- Protein IDQ6ZN28
- Protein NameMetastasis-associated in colon cancer protein 1
- Scientific DescriptionMetastasis associated in colon cancer 1 (MACC1) is a key regulator of the hepatocyte growth factor (HGF)-HGF receptor (MET) pathway, which is involved in cellular growth, epithelial-mesenchymal transition, angiogenesis, cell motility, invasiveness, and metastasis. MACC1 protein consists of four domains: ZU5, SH3, and two C-terminal death domains (DD). Expression of MACC1 was found significantly upregulated in malignant tissues (colon cancer of all stages as well as liver and lung metastases) compared to normal tissues or adenomas. MACC1 represents an early and crucial prognostic indicator for colon cancer metastasis that is independent of age, sex, tumor infiltration, nodal status, and lymph vessel invasion. Besides its involvement in signal transduction with the MET receptor, MACC1 also links MET signaling and apoptosis. MACC1 may also be an important therapeutic target for colorectal cancer treatment. At least two isoforms of MACC1 are known to exist.
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203